Parkman Healthcare Partners’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Parkman Healthcare Partners’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-491,272	Closed	-$16.4M	–	104
2024 Q3	$16.4M	Sell	491,272 -202,906	-29%	-$6.99M	2.09%	13
2024 Q2	$18.8M	Buy	694,178 +1,034	+0.1%	+$20.4K	2.51%	8
2024 Q1	$15M	Buy	693,144 +263,252	+61%	+$5.74M	1.84%	16
2023 Q4	$2.59M	Buy	429,892 +73,935	+21%	+$368K	0.37%	69
2023 Q3	$1.98M	Buy	355,957 +14,370	+4%	+$92.5K	0.36%	74
2023 Q2	$2.51M	Buy	+341,587	New	+$2.59M	0.43%	63

Parkman Healthcare Partners's LBPH Position: Q4 2024 in Review

Parkman Healthcare Partners sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 491,272 shares — an estimated $16.4M sold.

Parkman Healthcare Partners first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $18.8M in Q2 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Parkman Healthcare Partners reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Parkman Healthcare Partners sold 491,272 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $16.4M.
Parkman Healthcare Partners first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
Parkman Healthcare Partners's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $18.8M in Q2 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Parkman Healthcare Partners's 13F filing for Q4 2024, filed 14 Feb 2025.